Earnings Outlook For BioRestorative Therapies
BioRestorative Therapies (NASDAQ:BRTX) is gearing up to announce its quarterly earnings on Tuesday, 2025-08-12. Here's a quick overview of what investors should know before the release.
Analysts are estimating that BioRestorative Therapies will report an earnings per share (EPS) of $-0.41.
Anticipation surrounds BioRestorative Therapies's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings Track Record
During the last quarter, the company reported an EPS missed by $0.32, leading to a 2.34% drop in the share price on the subsequent day.
Here's a look at BioRestorative Therapies's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.27 | -0.43 | -0.56 |
| EPS Actual | -0.64 | -0.20 | -0.13 | -0.50 |
| Price Change % | -2.0% | -1.0% | -6.0% | -1.0% |
Market Performance of BioRestorative Therapies's Stock
Shares of BioRestorative Therapies were trading at $1.44 as of August 08. Over the last 52-week period, shares are up 2.01%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
